Blog - Page 3362 of 5566

MondayMay 09, 2011 8:41 am

NovaBay Pharmaceuticals Inc. (NBY) Showcases 3 New Biotech Compounds at Florida Ophthalmology Conference

NovaBay Pharmaceuticals Inc., a clinical-stage biotech company developing compounds to fight bacteria, fungi and viruses, presented a poster at the 2011 Conference of the Association for Research in Vision and Ophthalmology (ARVO) held this week in Fort Lauderdale, Fla. The poster, titled “AganocideÂ® Compounds Effective Against Ophthalmic Pathogens,” highlights three new Aganocide compounds similar to NovaBay’s lead anti-infective Aganocide compound, NVC-422. Novabay’s NVC-727, NVC-638, and NVC-704 compounds are broad-spectrum, fast-acting antimicrobial agents designed with the same mechanism of action but different activity profiles. The three new compounds expand Novabay’s current portfolio of Aganocide compounds and open a door for the…

MondayMay 09, 2011 8:40 am

PhotoMedex, Inc. (PHMD) Introduces DNA Damage Control Product

PhotoMedex, Inc., an industry leader of clinical skincare and laser products, introduced their innovative DNA Damage Control product. This product is much different than typical treatments and sunscreens in that it uses DNA to repair damaged skin. This product is being marketed under the company's NEOVA brand. DNA Damage Control defends against photodamage by boosting the body’s natural DNA repair process. The patent-pending formulas use liposomes to deliver DNA repair enzymes to the cellular level of the skin, hyper-targeting the site of the DNA injury. Clinical studies have shown that DNA repair enzymes reduced DNA damage by 45% and increased…

MondayMay 09, 2011 8:38 am

DUSA Pharmaceuticals Inc. (DUSA) Posts 27% Hike in Q1 Earnings

DUSA Pharmaceuticals Inc., a dermatology company developing and marketing products focused on patients with common skin conditions, Friday posted its first-quarter financials, reporting a 27 percent earnings increase. Revenues for the first quarter of 2011 were $11.1 million, up 27 percent compared to $8.7 million reported for the comparable quarter of 2010. The company widened its net loss for the quarter at $0.6 million, or $(0.02) per common share, compared to a net loss of $0.4 million, or ($0.02) per common share, in the first quarter of the year prior. As of March 31, 2011, the company had total cash,…

MondayMay 09, 2011 8:30 am

Max Media Group, Inc. (MXMI) is “One to Watch”

Max Media Group, Inc. is focused on providing monetized content to high-end, high impact social-based online community markets. Anyone, anywhere, can upload breaking news stories and high-end luxury items for sale by text, photo, or video through cell phones or other mobile devices on the Max Media Group's growing network of web sites. The company has formed an aggressive growth strategy to capture audiences and revenue through acquisitions and development of low cost of entry, rich interactive platforms in the highest valued advertising demographics. Max Media intends to leverage and monetize all of its websites through content and affiliate marketing. Today's…

MondayMay 09, 2011 8:25 am

EcoEmissions Solutions, Inc. (ECMZ) Spammed Aggressively over Weekend

We have observed an influx of emails spamming EcoEmissions Solutions, Inc. from various free email accounts over the weekend. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics…

FridayMay 06, 2011 10:25 pm

Solta Medical, Inc. (SLTM) Receives 501k Clearance from FDA for Clear + Brilliant Treatment

Solta Medical reported today reception of FDA 501k clearance for the Company’s Clear + Brilliant treatment, which had previously received CE mark and is based on SLTM’s fractional laser technology. The Clear + Brilliant treatment will be officially launched at the upcoming World Congress of Dermatology in Seoul, Korea. The advent of this new treatment would not have been possible without the Company’s mastery of fractional laser applications, as evident in SLTM’s Fraxel® treatment, which delivers minimally invasive clinical solutions for resurfacing aging/sun damaged skin. The Company started shipping the product to select/key international markets back in April and has…

FridayMay 06, 2011 10:25 pm

SinoTech Energy Ltd. (CTE) Raises Expectations for Fiscal Year 2011

Located in China, SinoTech has rapidly evolved as a provider of enhanced oil recovery (“EOR”) services. Today, the company announced an updated financial outlook for fiscal year 2011. SinoTech also told investors that it will release its unaudited financial results for the second quarter ended March 31, 2011, on May 19, 2011. Based on current business and operating conditions, SinoTech expects to report total sales in the range of US$100 million to US$105 million in fiscal year 2011. The numbers greatly exceed the previously announced range of US$90 million to US$95 million. Leading the way at SinoTech is Mr. Boxun…

FridayMay 06, 2011 10:25 pm

DUSA Pharmaceuticals (DUSA) Posts Higher Earnings, Wider Net Loss

DUSA Pharmaceuticals Inc., a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, reported a 27 percent increase in first-quarter revenues. “We are off to a great start in 2011,” Robert Doman, president and CEO of the DUSA stated in the press release. “Continued growth of our core domestic PDT revenues, as well as record gross margins, drove significant year-over-year improvement in our non-GAAP profitability and cash flow.” Total product revenues for the first quarter were $11.1 million, up 27 percent from $8.7 million in the first quarter…

FridayMay 06, 2011 10:24 pm

Zynex Inc. (ZYXI) Posts Q1 36% Earnings Increase, Reaffirms Q2 Guidance

Zynex Inc., a provider of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, yesterday posted a 36% increase in first quarter 2011 earnings. Net revenue of $6.63 million is an increase of 36 percent compared to $4.87 million for the quarter ended March 31, 2010. The company attributes the increase to its aggressive expansion efforts, including the addition of 18 new domestic sales representatives. Gross profit was $5.18 million compared to gross profit of $3.78 million reported for the first quarter of the year prior. The company reported a first quarter net loss of $110,000…

FridayMay 06, 2011 10:24 pm

MissionIR Breaks 10,000 Milestone on Facebook; Nears 50,000 Followers on Twitter

MissionIR is excited to announce that in just three months of establishing a presence on Facebook, it has gained over 10,000 Facebook friends. Through its social media accounts, MissionIR provides the latest market news as well as links to in-depth articles on promising companies trading on the AMEX and NASDAQ Exchanges. A spokesperson for MissionIR, stated, “Since the beginning our main goal has been to connect the investment community with companies that have great potential and a strong dedication to building shareholder value. Obviously the demand for an IR service that puts investors first is very strong and we continue…

Site Search

Company Search

NovaBay Pharmaceuticals Inc. (NBY) Showcases 3 New Biotech Compounds at Florida Ophthalmology Conference

PhotoMedex, Inc. (PHMD) Introduces DNA Damage Control Product

DUSA Pharmaceuticals Inc. (DUSA) Posts 27% Hike in Q1 Earnings

Max Media Group, Inc. (MXMI) is “One to Watch”

EcoEmissions Solutions, Inc. (ECMZ) Spammed Aggressively over Weekend

Solta Medical, Inc. (SLTM) Receives 501k Clearance from FDA for Clear + Brilliant Treatment

SinoTech Energy Ltd. (CTE) Raises Expectations for Fiscal Year 2011

DUSA Pharmaceuticals (DUSA) Posts Higher Earnings, Wider Net Loss

Zynex Inc. (ZYXI) Posts Q1 36% Earnings Increase, Reaffirms Q2 Guidance

MissionIR Breaks 10,000 Milestone on Facebook; Nears 50,000 Followers on Twitter

Market Basics

Newsletter Publishers

Public Companies